Takeda Pharmaceutical Co Ltd (NYSE:TAK)
$ 17.09 -0.16 (-0.93%) Market Cap: 54.58 Bil Enterprise Value: 82.61 Bil PE Ratio: 0 PB Ratio: 1.15 GF Score: 76/100

Q3 2024 Takeda Pharmaceutical Co Ltd Earnings Presentation Transcript

Feb 01, 2024 / 10:30AM GMT
Release Date Price: $14.38 (-1.51%)

Feb 01, 2024 / 10:30AM GMT
Presentation
Feb 01, 2024 / 10:30AM GMT

=====================
Corporate Participants
=====================
* Andrew S. Plump
Takeda Pharmaceutical Company Limited - President of Research & Development and Representative Director
* Christophe Weber
Takeda Pharmaceutical Company Limited - President, CEO & Representative Director
* Christopher David O'Reilly
Takeda Pharmaceutical Company Limited - Global Head of IR & Global Finance
* Constantine Saroukos
Takeda Pharmaceutical Company Limited - CFO & Representative Director
* Julie Kim
Takeda Pharmaceutical Company Limited - President of the U.S. Business Unit & U.S. Country Head
* Milano Furuta
Takeda Pharmaceutical Company Limited - President of Japan Pharma Business Unit

=====================
Conference Call Participants
=====================
* Hidemaru Yamaguchi
Citigroup Inc., Research Division - Research Analyst
* Hiroyuki Matsubara
Nomura Securities Co. Ltd., Research Division - Research

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot